Bahl & Gaynor Inc Merck & Co., Inc. Transaction History
Bahl & Gaynor Inc
- $19.6 Billion
- Q1 2025
A detailed history of Bahl & Gaynor Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Bahl & Gaynor Inc holds 3,740,595 shares of MRK stock, worth $306 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
3,740,595
Previous 4,320,178
13.42%
Holding current value
$306 Million
Previous $430 Million
21.88%
% of portfolio
1.72%
Previous 2.28%
Shares
34 transactions
Others Institutions Holding MRK
# of Institutions
3,882Shares Held
1.93BCall Options Held
25.6MPut Options Held
24M-
Vanguard Group Inc Valley Forge, PA253MShares$20.6 Billion0.42% of portfolio
-
Black Rock Inc. New York, NY207MShares$16.9 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$9.85 Billion0.46% of portfolio
-
Wellington Management Group LLP Boston, MA81.7MShares$6.68 Billion1.46% of portfolio
-
Geode Capital Management, LLC Boston, MA59.7MShares$4.88 Billion0.43% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $207B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...